192
Participants
Start Date
May 7, 2018
Primary Completion Date
August 1, 2024
Study Completion Date
March 3, 2025
ASTX029
PiB
ASTX029
Tablet
Hospital Universitario Dexeus Site#241, Barcelona
Columbia University Irving Medical Center - Herbert Irving Pavilion Site#112, New York
Hôpital de la Timone Site #201, Marseille
University of Pennsylvania-Abramson Cancer Center, Philadelphia
The Sidney Kimmel Comprehensive Cancer Center Site#106, Baltimore
Virginia Cancer Specialists Site#102, Fairfax
Clinica Universidad de Navarra Madrid Site #242, Madrid
Clínica Universidad de Navarra Site#242, Madrid
University of Michigan Rogel Cancer Center Site #113, Ann Arbor
Holden Comprehensive Cancer Center, Iowa City
Centre Léon Bérard Service d'Oncologie Médicale Site#202, Lyon
The University of Texas MD Anderson Cancer Center Site#111, Houston
START - South Texas Accelerated Research Therapeutics, LLC Site# 101, San Antonio
University of Southern California Norris Comprehensive Cancer Center Site#114, Los Angeles
Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute Site# 107, Los Angeles
City of Hope Comprehensive Cancer Center, Duarte
Hoag Memorial Hospital Site#115, Newport Beach
University of California Davis Medical Center Site #121, Sacramento
Providence Portland Medical Center Site #118, Portland
Oregon Health and Science University Site #122, Portland
California Pacific Medical Center - Sutter Pacific Medical Center Site#117, San Francisco
Smilow Cancer Hospital at Yale New Haven Site#105, New Haven
Massachusetts General Hospital Site#103, Boston
Dana Farber Cancer Institute Site#104, Boston
Institut Català d'Oncologia Badalona Site#240, Barcelona
Hospital Universitari Vall d'Hebrón Servicio de Oncología, Sala coordinación UITM Site#243, Barcelona
Hospital Universitari Germans Trias i Pujol, Barcelona
The Christie NHS Foundation Trust Site#220, Manchester
Cambridge University Hospitals NHS Foundation Trust, Cambridge
The Newcastle Upon Tyne Hospitals NHS Foundation Trust Site #221, Newcastle upon Tyne
Churchill Hospital Site #224, Oxford
Taiho Oncology, Inc.
INDUSTRY